Factors associated with medication adherence and perceived treatment barriers among Nepali women with polyendocrine metabolic ovarian syndrome: A cross- sectional study
Journal of Public Health Research · 2026-07 · 15 (3)
DOI: 10.1177/22799036261465332 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Public Health Research, online erschienen am 03.07.2026. Verfasst von Sajana Basnet und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, CiST College, Pokhara University, Baneshwor, Kathmandu, Nepal. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Effective management of Polyendocrine Metabolic Ovarian Syndrome (PMOS) depends on sustained medication adherence, yet evidence on adherence patterns and treatment barriers in low-resource settings remains limited.
Objectives
This study assessed factors associated with medication adherence and perceived treatment barriers among Nepalese women with PMOS.
Design
Cross-sectional study.
Methods
A total of 145 women aged 18–49 years diagnosed with PMOS at an infertility center in Kathmandu were enrolled between December 2023 and May 2024. Data were collected via face-to-face interviews using the General Medication Adherence Scale (GMAS) and a Barriers Assessment Questionnaire. Chi-square tests and unadjusted odds ratios (uOR) with 95% confidence intervals (CI) identified associations.
Results
Suboptimal adherence was observed in 66.3% of participants and 65.5% reported high treatment barriers. The factors associated withsuboptimal adherence included never-married status (uOR: 4.01; 95% CI: 1.87–8.43), lower educational attainment (illiterate: uOR: 1.40; 95% CI: 1.02–4.46; primary level: uOR: 1.38; 95% CI: 1.12–5.22), homemaker (uOR: 0.61; 95% CI: 0.29–0.88) or unemployed status (uOR: 0.91; 95% CI: 0.28–0.98), residence outside Kathmandu Valley (uOR: 0.95; 95% CI: 0.48–0.98), and smoking (uOR: 10.8; 95% CI: 1.23–95.2). High barriers were more likely among homemakers (uOR: 1.33; 95% CI: 1.13–2.80) and those outside Kathmandu Valley (uOR: 2.49; 95% CI: 1.21–5.14). Limited resources (p=0.028) and perceived symptomatic relief (p=0.011) were significantly associated with adherence.
Conclusion
Medication adherence was suboptimal, with barriers shaped by sociodemographic and healthcare access factors. Targeted interventions, rural outreach, patient education, and improved resource availability are essential to optimize PMOS treatment outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, CiST College, Pokhara University, Baneshwor, Kathmandu, Nepal.
- Department of Public Health, CiST College, Pokhara University, Baneshwor, Kathmandu, Nepal.
- National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australian Capital Territory, Australia.
- Department of Pharmacy, Shree College of Technology, Purbanchal University, Bharatpur, Nepal.
ORCID-Profile: Nirmal Raj Marasine, Shishir Paudel
Zitieren
APA
Basnet, S., Marasine, N. R., Paudel, S., Pant, P., & Sankhi, S. (2026). Factors associated with medication adherence and perceived treatment barriers among Nepali women with polyendocrine metabolic ovarian syndrome: A cross- sectional study. Journal of Public Health Research, 15(3). https://doi.org/10.1177/22799036261465332
Vancouver
Basnet S, Marasine NR, Paudel S, Pant P, Sankhi S. Factors associated with medication adherence and perceived treatment barriers among Nepali women with polyendocrine metabolic ovarian syndrome: A cross- sectional study. Journal of Public Health Research. 2026;15(3). doi:10.1177/22799036261465332
BibTeX
@article{Basnet2026,
author = {Basnet, Sajana and Marasine, Nirmal Raj and Paudel, Shishir and Pant, Poonam and Sankhi, Sabina},
title = {Factors associated with medication adherence and perceived treatment barriers among Nepali women with polyendocrine metabolic ovarian syndrome: A cross- sectional study},
journal = {Journal of Public Health Research},
year = {2026},
volume = {15},
number = {3},
doi = {10.1177/22799036261465332}
}
EUVIMED